Brief: Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Dermapharm Holding SE

15/12/2021 13:04

Dec 15 (Reuters) - Canopy Growth Corp  WEED.TO :
    * CANOPY GROWTH DIVESTS PHARMACEUTICAL C3 CANNABINOID
COMPOUND
COMPANY
    * CANOPY GROWTH CORP - AGREEMENT TO DIVEST ITS SUBSIDIARY
BUSINESS, C3 CANNABINOID COMPOUND COMPANY, TO DERMAPHARM HOLDING
SE
    * CANOPY GROWTH CORP - EXPECTED TO AVOID FUTURE OPERATIONAL
COMPLEXITIES AND IS REDUCING SHORT-TERM CAPITAL INVESTMENT
REQUIREMENTS BY OVER CAD$50M
    * CANOPY GROWTH CORP - AN UPFRONT PAYMENT OF EUR80 MILLION
WILL BE
MADE UPON CLOSING OF TRANSACTION

Source text for Eikon:  ID:nPn2c8HWWa 
Further company coverage:  WEED.TO 

 ((Reuters.Briefs@thomsonreuters.com;))